Vertex Pharmaceuticals Claimed Company
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases.
read more
HR or Marketing? Claim Your Free Employer Account
Patricia Hurter ā Senior Vice President, of Pharmaceutical and Preclinical Sciences at Vertex Pharmaceuticals
Executive Bio
Dr. Patricia Hurter, Ph.D. serves as Senior Vice President, Pharmaceutical and Preclinical Sciences and served as Senior Vice President of CMC and Preclinical Development of Vertex Pharmaceuticals Incorporated. Dr. Hurter joined Vertex in 2004 as Head of Formulation Development, became the Vice President of Pharmaceutical Development in 2006. Prior to joining Vertex, Dr. Hurter was Director of Formulation Development at Merck from 2000 to 2004. Before joining the pharmaceutical industry, Dr. Hurter worked in the paper industry for 8 years where she studied the microstructure of paper and its effects on end use performance. Dr. Hurter has a Ph.D. in Chemical Engineering from M.I.T., an M.S. in Mechanical Engineering from West Virginia University and a B.Sc. in Chemical Engineering from the University of Natal, Durban, South Africa.
Executive Team Culture Ratings from Vertex Pharmaceuticals Employees
TOP
5%
Vertex Pharmaceuticals' Executive Team scores in the Top 5%
of similar sized companies on Comparably
of similar sized companies on Comparably
Vertex Pharmaceuticals' Executive Team at a Glance
Based on 35 ratings, Vertex Pharmaceuticals' employees are very satisfied with their Executive Team and give them an āA+ā or 83/100. On average, Women provided higher ratings for their Executive Team compared to Men.
Vertex Pharmaceuticals' Executive Team ranks in the Top 10% of other companies in Boston and Top 5% of other companies on Comparably that also have 1,001-5,000 Employees.
×